← Back to Search

Patients with suspected Barrett's Esophagus or at risk for esophageal cancer for Esophageal Cancer (BEST-RPP Trial)

N/A
Recruiting
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 months
Awards & highlights
No Placebo-Only Group

Summary

Recent advancements in swallowable esophageal cell-collection devices (SECD) offer a safe, minimally invasive, accurate, and low-cost alternative to esophageal screening without the need for an upper endoscopy. The BEST-RPP study aims to evaluate the acceptability and feasibility of using this novel approach to screen for Barrett's Esophagus (BE) and Esophageal Carcinoma (EAC) in rural primary care clinic settings in Oregon.

Eligible Conditions
  • Esophageal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of the use of SECD: Number enrolled
Feasibility of the use of SECD: Number of providers who indicate willingness to be trained and train clinic staff
Feasibility of the use of SECD: Number of referrals
+4 more
Secondary study objectives
Access: time to full diagnostic work up for patients with positive SECD results

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients with suspected Barrett's Esophagus or at risk for esophageal cancerExperimental Treatment1 Intervention
Patients who receive primary care in a rural settings and are in need of screening for Barrett's Esophagus or esophageal cancer.

Find a Location

Who is running the clinical trial?

OHSU Knight Cancer InstituteLead Sponsor
235 Previous Clinical Trials
2,088,470 Total Patients Enrolled
Kuni FoundationUNKNOWN
2 Previous Clinical Trials
162 Total Patients Enrolled
Oregon Health and Science UniversityOTHER
1,003 Previous Clinical Trials
7,412,280 Total Patients Enrolled
~18 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top